Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation

被引:22
作者
Flynn, S [1 ]
Stockinger, B [1 ]
机构
[1] Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England
关键词
D O I
10.1182/blood-2002-10-3030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper addresses the capacity of naive, effector, and memory CD4 T cells to control growth of a major histocompatibility complex (MHC) class II-positive B-cell lymphoma in vivo. To assess the role of T cells on their own without contributions by B cells, antibodies, or natural killer (NK) cells, we generated pure effector or memory CD4 T cells in Rag(-/-)gc(-/-) mice deficient in endogenous lymphocytes and NK cells. Lymphoma cells expressing a model antigen were injected into mice with T cells of cognate specificity that were either naive or in effector or resting memory state. Naive T cells were unable to prevent tumor growth, probably due to delay of efficient cross-presentation by dendritic cells. However, both effector and memory T cells, dependent on the amount of antigen available, controlled the tumor for a considerable period of time without the need for dendritic cell stimulation. Nevertheless, the tumor eventually grew uncontrolled in all cases. This was not because of a defect in T-cell homing to the tumor site or loss of MHC class II or costimulatory molecules by the tumor, but reflected mutual paralysis of T-cell responsiveness and antigen processing by tumor cells. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:4472 / 4478
页数:7
相关论文
共 72 条
[11]   IFN-αβ promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines [J].
Cho, HJ ;
Hayashi, T ;
Datta, SK ;
Takabayashi, K ;
Van Uden, JH ;
Horner, A ;
Corr, M ;
Raz, E .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :4907-4913
[12]   Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis [J].
Coughlin, CM ;
Salhany, KE ;
Gee, MS ;
LaTemple, DC ;
Kotenko, S ;
Ma, XJ ;
Gri, G ;
Wysocka, M ;
Kim, JE ;
Liu, L ;
Liao, F ;
Farber, JM ;
Pestka, S ;
Trinchieri, G ;
Lee, WMF .
IMMUNITY, 1998, 9 (01) :25-34
[13]   PROTECTION AGAINST SYNGENEIC LYMPHOMA BY A LONG-LIVED CYTO-TOXIC T-CELL CLONE [J].
DAILEY, MO ;
PILLEMER, E ;
WEISSMAN, IL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (17) :5384-5387
[14]   ENHANCED IN-VIVO GROWTH AND RESISTANCE TO REJECTION OF TUMOR-CELLS EXPRESSING DOMINANT-NEGATIVE IFN-GAMMA RECEPTORS [J].
DIGHE, AS ;
RICHARDS, E ;
OLD, LJ ;
SCHREIBER, RD .
IMMUNITY, 1994, 1 (06) :447-456
[15]   GENE-TRANSFER AS CANCER-THERAPY [J].
DRANOFF, G ;
MULLIGAN, RC .
ADVANCES IN IMMUNOLOGY, VOL 58, 1995, 58 :417-454
[16]   VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].
DRANOFF, G ;
JAFFEE, E ;
LAZENBY, A ;
GOLUMBEK, P ;
LEVITSKY, H ;
BROSE, K ;
JACKSON, V ;
HAMADA, H ;
PARDOLL, D ;
MULLIGAN, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543
[17]   Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity [J].
Dredge, K ;
Marriott, JB ;
Todryk, SM ;
Muller, GW ;
Chen, R ;
Stirling, DI ;
Dalgleish, AG .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :4914-4919
[18]   Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells [J].
Fiebiger, E ;
Meraner, P ;
Weber, E ;
Fang, IF ;
Stingl, G ;
Ploegh, H ;
Maurer, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (08) :881-892
[19]   Antiangiogenic gene therapy [J].
Folkman, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9064-9066
[20]  
FUJIWARA H, 1984, J IMMUNOL, V133, P1671